{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T09:12:27Z","timestamp":1780909947658,"version":"3.54.1"},"reference-count":105,"publisher":"European Respiratory Society (ERS)","issue":"3","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2026,1,29]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>Acute exacerbations of COPD (AECOPD) are a major cause of morbidity and mortality, with systemic effects beyond the lung complicating treatment and recovery. Understanding the multisystem impact of AECOPD, as well as established and emerging approaches to mitigate these issues, is important for optimising patient management. This review explores the systemic impact of hospitalisation with AECOPD, such as the primary pulmonary and systemic inflammatory burden, the effects of prolonged inactivity and consequences of specific treatments. Complications include an increased risk of cardiovascular events, hyperglycaemia, cognitive impairment and confusion, and loss of muscle mass and function. These effects share several key pathophysiological features, including high-grade systemic inflammation and hypoxaemia-induced impairments to cellular energy production. Many of these systemic consequences have substantial implications for patients\u2019 health and quality of life beyond that of the primary lung insult. As such, recognising and treating these effects are crucial in the management of AECOPD. These treatments should be specified based on the presenting features, though cornerstones include regulation of blood oxygen and glucose levels, limited use of glucocorticoids, nutritional management and post-exacerbation pulmonary rehabilitation. Several emerging pharmacological compounds have demonstrated promise in addressing some systemic effects. The systemic impact of AECOPD is widespread, with major consequences for short- and long-term outcomes. By mapping this diverse body of evidence, this narrative review highlights the need to recognise and treat systemic effects alongside the primary pulmonary insult and identifies promising avenues for novel management strategies.<\/jats:p>","DOI":"10.1183\/23120541.01725-2025","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:55:18Z","timestamp":1771268118000},"page":"01725-2025","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The systemic impact of acute exacerbations of COPD requiring hospitalisation: a narrative review"],"prefix":"10.1183","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3907-6753","authenticated-orcid":false,"given":"George","family":"Mills","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4504-5099","authenticated-orcid":false,"given":"Joseph","family":"Kibbler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna","family":"Latimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8997-0764","authenticated-orcid":false,"given":"Hamish J.C.","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Steer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0453-7529","authenticated-orcid":false,"given":"Neil J.","family":"Greening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"2026060801451604000_12.3.01725-2025.1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global Strategy for Prevention, Diagnosis and Management of COPD: 2024 Report. Date last accessed: 1 September 2025. https:\/\/goldcopd.org\/"},{"key":"2026060801451604000_12.3.01725-2025.2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00043710"},{"key":"2026060801451604000_12.3.01725-2025.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0909883"},{"key":"2026060801451604000_12.3.01725-2025.4","unstructured":"Stone RA , Holzhauer\u2010Barrie J, Lowe D, et al. COPD: Who Cares When it Matters Most? National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme: Outcomes from the Clinical Audit of COPD Exacerbations Admitted to Acute Units in England 2014. National Supplementary Report. London, The Royal College of Physicians, 2017."},{"key":"2026060801451604000_12.3.01725-2025.5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-2521"},{"key":"2026060801451604000_12.3.01725-2025.6","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00128008"},{"key":"2026060801451604000_12.3.01725-2025.7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA: a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res Integr Peer Rev"},{"key":"2026060801451604000_12.3.01725-2025.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0800353"},{"key":"2026060801451604000_12.3.01725-2025.9","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf257"},{"key":"2026060801451604000_12.3.01725-2025.10","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.01157.2007"},{"key":"2026060801451604000_12.3.01725-2025.11","doi-asserted-by":"publisher","DOI":"10.1186\/cc2918"},{"key":"2026060801451604000_12.3.01725-2025.12","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-7678-9_21"},{"key":"2026060801451604000_12.3.01725-2025.13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037483"},{"key":"2026060801451604000_12.3.01725-2025.14","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2003.019588"},{"key":"2026060801451604000_12.3.01725-2025.15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejim.2024.04.021","article-title":"Cardiovascular events after exacerbations of chronic obstructive pulmonary disease: results from the EXAcerbations of COPD and their OutcomeS in CardioVascular diseases study in Italy","volume":"127","author":"Calabria","year":"2024","journal-title":"Eur J Intern Med"},{"key":"2026060801451604000_12.3.01725-2025.16","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.01091-2024"},{"key":"2026060801451604000_12.3.01725-2025.17","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1164\/rccm.202307-1122OC","article-title":"Temporal risk of nonfatal cardiovascular events after chronic obstructive pulmonary disease exacerbation: a population-based study","volume":"209","author":"Graul","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060801451604000_12.3.01725-2025.18","doi-asserted-by":"crossref","unstructured":"Kibbler J , Wade C , Mussell G , et al. Systematic review and meta-analysis of prevalence of undiagnosed major cardiac comorbidities in COPD. ERJ Open Res 2023; 9: 00548-2023. doi:10.1183\/23120541.00548-2023","DOI":"10.1183\/23120541.00548-2023"},{"key":"2026060801451604000_12.3.01725-2025.19","doi-asserted-by":"crossref","unstructured":"Kibbler J , Pakpahan E , McCarthy S , et al. Structured cardiac assessment and treatment following exacerbations of COPD (SCATECOPD): a pilot randomised controlled trial. Biomedicines 2025; 13: 658. doi:10.3390\/biomedicines13030658","DOI":"10.3390\/biomedicines13030658"},{"key":"2026060801451604000_12.3.01725-2025.20","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1164\/rccm.202404-0838OC","article-title":"Prevalence and clinical correlates of radiologically detected coronary artery disease in COPD: a cross-sectional observational study","volume":"211","author":"MacLeod","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060801451604000_12.3.01725-2025.21","first-page":"23","article-title":"Beta-blocker, aspirin, and statin usage after first-time myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide analysis from 1995 to 2015 in Denmark","volume":"6","author":"Rasmussen","year":"2019","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026060801451604000_12.3.01725-2025.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2015.05.006"},{"key":"2026060801451604000_12.3.01725-2025.23","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2764"},{"key":"2026060801451604000_12.3.01725-2025.24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201306-1170OC"},{"key":"2026060801451604000_12.3.01725-2025.25","doi-asserted-by":"crossref","first-page":"e0274585","DOI":"10.1371\/journal.pone.0274585","article-title":"Cardiovascular effects of exercise induced dynamic hyperinflation in COPD patients: dynamically hyperinflated and non-hyperinflated subgroups","volume":"18","author":"Lukacsovits","year":"2023","journal-title":"PLoS ONE"},{"key":"2026060801451604000_12.3.01725-2025.26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.rmed.2018.11.008","article-title":"Changes in biomarkers of cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease","volume":"145","author":"Shafuddin","year":"2018","journal-title":"Respir Med"},{"key":"2026060801451604000_12.3.01725-2025.27","doi-asserted-by":"crossref","unstructured":"Rastoder E , Sivapalan P , Hedsund C , et al. Pulmonary pressure increases during acute exacerbation in COPD and clinical outcome. Eur Respir J 2025; 66: 2500169. doi:10.1183\/13993003.00169-2025","DOI":"10.1183\/13993003.00169-2025"},{"key":"2026060801451604000_12.3.01725-2025.28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03377.x"},{"key":"2026060801451604000_12.3.01725-2025.29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcma.2017.10.003","article-title":"Changes of heart rate variability predicting patients with acute exacerbation of chronic obstructive pulmonary disease requiring hospitalization after Emergency Department treatment","volume":"81","author":"Tseng","year":"2018","journal-title":"J Chin Med Assoc"},{"key":"2026060801451604000_12.3.01725-2025.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-013-9544-7"},{"key":"2026060801451604000_12.3.01725-2025.31","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-2029"},{"key":"2026060801451604000_12.3.01725-2025.32","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.arbres.2025.02.004","article-title":"All-cause and cardiovascular mortality with single inhaler triple therapy versus double therapies for COPD: a systematic review and metanalysis","volume":"61","author":"Hammadi","year":"2025","journal-title":"Arch Bronconeumol"},{"key":"2026060801451604000_12.3.01725-2025.33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202312-2311OC"},{"key":"2026060801451604000_12.3.01725-2025.34","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202006-2618OC"},{"key":"2026060801451604000_12.3.01725-2025.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1403086"},{"key":"2026060801451604000_12.3.01725-2025.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908142"},{"key":"2026060801451604000_12.3.01725-2025.37","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.2024.8771","article-title":"Bisoprolol in patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS randomized clinical trial","volume":"332","author":"Devereux","year":"2024","journal-title":"JAMA"},{"key":"2026060801451604000_12.3.01725-2025.38","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00756-2020"},{"key":"2026060801451604000_12.3.01725-2025.39","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD) . Global Strategy for the Diagnosis, Management, and Prevention of of Chronic Obstructive Pulmonary Disease: 2026 Report. Date last accessed: 1 December 2025. https:\/\/goldcopd.org\/2026-gold-report-and-pocket-guide\/"},{"key":"2026060801451604000_12.3.01725-2025.40","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.2147\/COPD.S471952","article-title":"A multi-specialty Delphi consensus on assessing and managing cardiopulmonary risk in patients with COPD","volume":"19","author":"Bhutani","year":"2024","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026060801451604000_12.3.01725-2025.41","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3109\/15412555.2015.1081883","article-title":"Changes in cognitive status in COPD patients across clinical stages","volume":"13","author":"L\u00f3pez-Torres","year":"2016","journal-title":"COPD"},{"key":"2026060801451604000_12.3.01725-2025.42","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/imj.14259","article-title":"Cognitive function during exacerbations of chronic obstructive pulmonary disease","volume":"49","author":"Poot","year":"2019","journal-title":"Intern Med J"},{"key":"2026060801451604000_12.3.01725-2025.43","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-3035"},{"key":"2026060801451604000_12.3.01725-2025.44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CIA.S185981","article-title":"COPD patients hospitalized with exacerbations have greater cognitive impairment than patients hospitalized with decompensated heart failure","volume":"14","author":"Bajaj","year":"2019","journal-title":"Clin Interv Aging"},{"key":"2026060801451604000_12.3.01725-2025.45","doi-asserted-by":"crossref","first-page":"e102468","DOI":"10.1371\/journal.pone.0102468","article-title":"Cognitive impairment in chronic obstructive pulmonary disease","volume":"9","author":"Crisan","year":"2014","journal-title":"PLoS ONE"},{"key":"2026060801451604000_12.3.01725-2025.46","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2099"},{"key":"2026060801451604000_12.3.01725-2025.47","doi-asserted-by":"crossref","first-page":"106249","DOI":"10.1016\/j.rmed.2020.106249","article-title":"Cognitive function following pulmonary rehabilitation and post-discharge recovery from exacerbation in people with COPD","volume":"176","author":"France","year":"2021","journal-title":"Respir Med"},{"key":"2026060801451604000_12.3.01725-2025.48","doi-asserted-by":"crossref","unstructured":"Anand A , Cheng M , Ibitoye T , et al. Positive scores on the 4AT delirium assessment tool at hospital admission are linked to mortality, length of stay and home time: two-centre study of 82,770 emergency admissions. Age Ageing 2022; 51: afac051. doi:10.1093\/ageing\/afac051","DOI":"10.1093\/ageing\/afac051"},{"key":"2026060801451604000_12.3.01725-2025.49","doi-asserted-by":"publisher","DOI":"10.4065\/81.10.1361"},{"key":"2026060801451604000_12.3.01725-2025.50","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-003-1005-4"},{"key":"2026060801451604000_12.3.01725-2025.51","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-021-00796-3"},{"key":"2026060801451604000_12.3.01725-2025.52","first-page":"199","article-title":"Hypoxemia in patients with COPD: cause, effects, and disease progression","volume":"6","author":"Kent","year":"2011","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026060801451604000_12.3.01725-2025.53","first-page":"H235","article-title":"Brain adenosine concentration during hypoxia in rats","volume":"241","author":"Winn","year":"1981","journal-title":"Am J Physiol"},{"key":"2026060801451604000_12.3.01725-2025.54","doi-asserted-by":"crossref","first-page":"108017","DOI":"10.1016\/j.pharmthera.2021.108017","article-title":"Novel pharmacological strategies to treat cognitive dysfunction in chronic obstructive pulmonary disease","volume":"233","author":"Dobric","year":"2022","journal-title":"Pharmacol Ther"},{"key":"2026060801451604000_12.3.01725-2025.55","doi-asserted-by":"publisher","DOI":"10.1378\/chest.88.2.239"},{"key":"2026060801451604000_12.3.01725-2025.56","first-page":"7","article-title":"Psychological status of COPD patients before and after one year of long-term oxygen therapy","volume":"51","author":"Borak","year":"1996","journal-title":"Monaldi Arch Chest Dis"},{"key":"2026060801451604000_12.3.01725-2025.57","doi-asserted-by":"publisher","DOI":"10.1089\/rej.2007.0607"},{"key":"2026060801451604000_12.3.01725-2025.58","doi-asserted-by":"crossref","first-page":"2517658","DOI":"10.1155\/2019\/2517658","article-title":"Responsiveness, minimal clinically important difference, and validity of the MoCA in stroke rehabilitation","volume":"2019","author":"Wu","year":"2019","journal-title":"Occup Ther Int"},{"key":"2026060801451604000_12.3.01725-2025.59","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-075847"},{"key":"2026060801451604000_12.3.01725-2025.60","unstructured":"National Institute for Health and Care Excellence ( NICE) . Delirium: prevention, diagnosis and management in hospital and long-term care. 2010. Date last updated: 18 January 2023. Date last accessed: 1 September 2025. www.nice.org.uk\/guidance\/cg103\/chapter\/Recommendations#:\u223c:text=1"},{"key":"2026060801451604000_12.3.01725-2025.61","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003299"},{"key":"2026060801451604000_12.3.01725-2025.62","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0049-2019"},{"key":"2026060801451604000_12.3.01725-2025.63","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.3.9612102"},{"key":"2026060801451604000_12.3.01725-2025.64","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.9.752"},{"key":"2026060801451604000_12.3.01725-2025.65","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200908-1203OC"},{"key":"2026060801451604000_12.3.01725-2025.66","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.medcli.2018.03.012","article-title":"Efficacy of combined electrostimulation in patients with acute exacerbation of COPD: randomised clinical trial","volume":"151","author":"Lopez Lopez","year":"2018","journal-title":"Med Clin (Barc)"},{"key":"2026060801451604000_12.3.01725-2025.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2014.05.007"},{"key":"2026060801451604000_12.3.01725-2025.68","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.04597"},{"key":"2026060801451604000_12.3.01725-2025.69","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215949"},{"key":"2026060801451604000_12.3.01725-2025.70","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.3.536"},{"key":"2026060801451604000_12.3.01725-2025.71","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00235"},{"key":"2026060801451604000_12.3.01725-2025.72","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2007.142828"},{"key":"2026060801451604000_12.3.01725-2025.73","doi-asserted-by":"publisher","DOI":"10.1007\/s00421-009-1136-0"},{"key":"2026060801451604000_12.3.01725-2025.74","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.161.4.9903022"},{"key":"2026060801451604000_12.3.01725-2025.75","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2013.05.036"},{"key":"2026060801451604000_12.3.01725-2025.76","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4315"},{"key":"2026060801451604000_12.3.01725-2025.77","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/HCR.0000000000000230","article-title":"Resistance training with ankle weight cuffs is feasible in patients with acute exacerbation of COPD","volume":"37","author":"Kofod","year":"2017","journal-title":"J Cardiopulm Rehabil Prev"},{"key":"2026060801451604000_12.3.01725-2025.78","doi-asserted-by":"publisher","DOI":"10.1378\/chest.114.1.19"},{"key":"2026060801451604000_12.3.01725-2025.79","doi-asserted-by":"crossref","unstructured":"Jenkins AR , Gaynor-Sodeifi K , Lewthwaite H , et al. Efficacy of interventions to alter measures of fat-free mass in people with COPD: a systematic review and meta-analysis. ERJ Open Res 2023; 9: 00102-2023. doi:10.1183\/23120541.00102-2023","DOI":"10.1183\/23120541.00102-2023"},{"key":"2026060801451604000_12.3.01725-2025.80","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2008.01.013"},{"key":"2026060801451604000_12.3.01725-2025.81","doi-asserted-by":"crossref","first-page":"e2076","DOI":"10.1002\/pri.2076","article-title":"Effectiveness of neuromuscular electrical stimulation in patients with acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"29","author":"Okura","year":"2024","journal-title":"Physiother Res Int"},{"key":"2026060801451604000_12.3.01725-2025.82","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2021-218360"},{"key":"2026060801451604000_12.3.01725-2025.83","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201802-0286OC"},{"key":"2026060801451604000_12.3.01725-2025.84","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.3390\/nu16193271","article-title":"Emerging targets and treatments for sarcopenia: a narrative review","volume":"16","author":"Cacciatore","year":"2024","journal-title":"Nutrients"},{"key":"2026060801451604000_12.3.01725-2025.85","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00791-2016"},{"key":"2026060801451604000_12.3.01725-2025.86","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2023-220439"},{"key":"2026060801451604000_12.3.01725-2025.87","first-page":"289","article-title":"Factors contributing to muscle wasting and dysfunction in COPD patients","volume":"2","author":"W\u00fcst","year":"2007","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026060801451604000_12.3.01725-2025.88","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.118638"},{"key":"2026060801451604000_12.3.01725-2025.89","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.106989"},{"key":"2026060801451604000_12.3.01725-2025.90","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.97.10102264"},{"key":"2026060801451604000_12.3.01725-2025.91","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.8.819"},{"key":"2026060801451604000_12.3.01725-2025.92","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-4887.2010.00298.x"},{"key":"2026060801451604000_12.3.01725-2025.93","doi-asserted-by":"publisher","DOI":"10.1016\/S0749-0704(05)70154-8"},{"key":"2026060801451604000_12.3.01725-2025.94","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-9-30"},{"key":"2026060801451604000_12.3.01725-2025.95","unstructured":"Medicines and Healthcare Products Regulatory Agency . SGLT2 inhibitors: monitor ketones in blood during treatment interruption for surgical procedures or acute serious medical illness. 2020. Date last updated: 18 March 2020. Date last accessed: 1 September 2025. www.gov.uk\/drug-safety-update\/sglt2-inhibitors-monitor-ketones-in-blood-during-treatment-interruption-for-surgical-procedures-or-acute-serious-medical-illness"},{"key":"2026060801451604000_12.3.01725-2025.96","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.4.9912016"},{"key":"2026060801451604000_12.3.01725-2025.97","first-page":"135","article-title":"Postprandial dyspnea and malnutrition in patients with chronic obstructive pulmonary disease","volume":"21","author":"Gray-Donald","year":"1998","journal-title":"Clin Invest Med"},{"key":"2026060801451604000_12.3.01725-2025.98","first-page":"361","article-title":"Meal-induced oxygen desaturation and dyspnea in chronic obstructive pulmonary disease","volume":"5","author":"Wolkove","year":"1998","journal-title":"Can Respir J"},{"key":"2026060801451604000_12.3.01725-2025.99","first-page":"67","article-title":"Diabetes and metabolic dysfunction in COPD","volume":"5","author":"Archer","year":"2009","journal-title":"Respiratory Medicine: COPD Update"},{"key":"2026060801451604000_12.3.01725-2025.100","unstructured":"Dhatariya K , Umpierrez GE . Management of diabetes and hyperglycemia in hospitalized patients. In: Feingold KR , et al. , ed. Endotext. South Dartmouth, MA, MDText.com, Inc, 2000."},{"key":"2026060801451604000_12.3.01725-2025.101","unstructured":"BAPEN . Managing Malnutrition in COPD. 2020. Date last updated: January 2020. www.bapen.org.uk\/pdfs\/copd-guidance\/copd-managing-malnutrition-brochure.pdf#:\u223c:text=and%20muscle%20mass%20%28lean%20tissue%29,of%20individuals%20with%20COPD%2C%20and"},{"key":"2026060801451604000_12.3.01725-2025.102","doi-asserted-by":"crossref","first-page":"00217-2022","DOI":"10.1183\/23120541.00217-2022","article-title":"All-cause admissions following a first ever exacerbation-related hospitalisation in COPD","volume":"9","author":"Waeijen-Smit","year":"2023","journal-title":"ERJ Open Res"},{"key":"2026060801451604000_12.3.01725-2025.103","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2013-203808"},{"key":"2026060801451604000_12.3.01725-2025.104","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2023-220615"},{"key":"2026060801451604000_12.3.01725-2025.105","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00171-2024"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.01725-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:46:06Z","timestamp":1780908366000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.01725-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":105,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6,8]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1183\/23120541.01725-2025"],"URL":"https:\/\/doi.org\/10.1183\/23120541.01725-2025","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]}}}